Description

A pancreatic cancer gene and antigen blood panel can help diagnose pancreatic cancer and guide treatment decisions.

The following test are included:

BRCA1 and BRCA2

CDKN2A

CA19-9

Fasting not required.

Additional information about each test is listed below:

BRCA1 and BRCA2 are tumor suppressor genes that can increase the risk of pancreatic cancer. These genes are involved in DNA repair, and mutations in them can cause cells to grow abnormally. 

A faulty CDKN2A gene increases the risk of developing pancreatic cancer. CDKN2A is a gene that helps protect against cancer, and loss of CDKN2A function is a major factor in pancreatic tumor development. 

A CA19-9 test measures the level of the protein CA19-9 in your blood to help monitor pancreatic cancer and other conditions. CA19-9 stands for carbohydrate antigen 19-9.